HWAM
ARNA

Hennion & Walsh Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,600
Closed -$613K – 818
2021
Q4 		$613K Sell
6,600
-137
-2% -$9.03K 0.03% 490
2021
Q3 		$401K Buy
6,737
+1,638
+32% +$96.8K 0.02% 559
2021
Q2 		$348K Buy
+5,099
New +$332K 0.02% 587

Hennion & Walsh Asset Management's ARNA Position: Q1 2022 in Review

Hennion & Walsh Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 6,600 shares — an estimated $613K sold.

Hennion & Walsh Asset Management first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $613K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Hennion & Walsh Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 6,600 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $613K.
  • Hennion & Walsh Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's Arena Pharmaceuticals Inc position peaked at $613K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.